J. Dahabre

Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)

Johan Vansteenkiste, M. Zieliński, A. Linder et al. · Journal of Clinical Oncology · 2007 · 149 citations

Surgical Oncology, Cancer Management, Immunology +18

Multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of recombinant MAGE-A3 vaccine as adjuvant therapy in stage IB/II MAGE-A3-positive, completely resected, non-small cell lung cancer (NSCLC)

Johan Vansteenkiste, M. Zieliński, J. Dahabre et al. · Journal of Clinical Oncology · 2006 · 30 citations

Surgical Oncology, Immunology, Adjuvant Chemotherapy +18

Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial

George Koumakis, M. Demiri, Vassilios Barbounis et al. · Lung Cancer · 2002 · 24 citations

Phase Ii Trial, Medicine, Clinical Trials +7